What is Zyden Gentec Ltd (530091) share price return in the past 10 years?

Data is not available for this company

What is the share price of Zyden Gentec Ltd (530091)?

Company share prices are keep on changing according to the market conditions. The current trading price of Zyden Gentec Ltd (530091) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Zyden Gentec?

The latest standalone P/E ratio of Zyden Gentec as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Zyden Gentec Ltd (530091)?

The latest standalone P/B ratio of Zyden Gentec Ltd (530091) as of 01-Jan-1970 is 0.37.

What is the 52-week high and low of Zyden Gentec Ltd (530091)?

The 52-week high of Zyden Gentec Ltd (530091) is Rs. 0.95 and the 52-week low is Rs. 0.87.

Zyden Gentec Ltd (530091) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Zyden Gentec Ltd (530091)
Brand: Zyden Gentec

Zyden Gentec Ltd (530091)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530091 NSE: Pharmaceuticals & Drugs | Small Cap | Zyden Gentec Share Price

Zyden Gentec Ltd (530091)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 530091 NSE: Pharmaceuticals & Drugs | Small Cap | Zyden Gentec Share Price

Key Metrics

Valuation Multiples

Market Cap

₹5 Cr.

Current Price

₹0

52-Week Low / High

₹1 / 1

TTM EPS

₹-0.7

TTM Sales

₹1.2 Cr.

Book Value per Share

₹2.4

P/E Ratio

0.00

Industry PE

46.5

Price to Book (P/B)

0.37

In line with its 5-year historical median

Price to Sales (P/S)

4.22

In line with its 5-year historical median

EV/EBITDA

-15.87

In line with its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

-47.91%

Underperforms industry median

Return on Capital Employed (ROCE)

-33.84%

Underperforms industry median

Return on Assets (ROA)

-32.82%

Operating Profit Margin

-37.7%

Net Profit Margin

-329.3%

Gross Profit Margin

-37.6%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Improving versus 3-year growth rate

55.41%

Operating Profit Growth (1 Year)

Net Profit Growth (1 Year)

Asset Quality

Promoter Holding

0.00%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹2 Cr.

Equity

₹11.1 Cr.

Face Value

₹2

All Time Low / High

₹0.16 / 35.80

Zyden Gentec stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Zyden Gentec Ltd a good quality company?

Zyden Gentec Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Zyden Gentec Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Zyden Gentec Ltd vs industry peers?

Zyden Gentec Ltd revenue CAGR is -6.27%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Zyden Gentec Ltd?

Promoters hold 0.00% of the Zyden Gentec Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Zyden Gentec Ltd over the last decade?

Over the last - year(s), the stock has delivered a CAGR of N/A% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
ROCE % ⓘ	5.7%	5.5%	-14.8%	-1.4%	-1%	-0%	-1.8%	-0.1%	-3.4%	-33.8%	-
Value Creation Index ⓘ	-0.6	-0.6	-2.1	-1.1	-1.1	-1.0	-1.1	-1.0	-1.2	-3.4	-
Growth Parameters ⓘ
Sales ⓘ	17.5	12.1	9.5	7.6	1.6	0.3	0.4	0.1	0.7	1.2	1
Sales YoY Gr.	-	-30.9%	-21.4%	-20.6%	-78.9%	-78.6%	5.9%	-86.1%	1,380%	55.4%	-
Adj EPS ⓘ	0	-0	-0.7	-0.1	-0.1	-0	0.1	-0	-0.3	-0.3	-0.7
YoY Gr.	-	-200%	NA	NA	NA	NA	NA	-100%	NA	NA	-
BVPS (₹) ⓘ	3.4	3.3	2.3	2.3	2.2	2.2	2.2	2.2	1.8	1.1	2.4
Adj Net Profit ⓘ	0.1	-0.1	-4.1	-0.7	-0.3	-0	0.3	-0	-1.5	-1.4	-4
Cash Flow from Ops. ⓘ	4	-1.6	-1.8	3.7	0.3	-0	-2.4	-0.5	-5.3	0.1	-
Debt/CF from Ops. ⓘ	1	-6.2	-6.3	3.2	37.9	-4897.5	-3.3	-14.7	-0.9	23.2	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	-26.1%	-6.3%	47.3%	55.4%
Adj EPS ⓘ	-223.1%	NA	-263%	NA
BVPSⓘ	-11.9%	-13.5%	-20.5%	-38.6%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19	TTM
Return on Equity % ⓘ	1.3	-1.2	-36.9	-5.7	-2	-0.3	2.8	-0.1	-14.2	-18.2	-39.3
Op. Profit Mgn % ⓘ	4.2	9.7	-30.5	-13.4	-81.1	-115.5	89.2	-24.2	48	-37.7	NAN
Net Profit Mgn % ⓘ	0.6	-0.9	-43	-9.7	-15.9	-12.2	96.3	-24.6	-207.5	-125.1	-328.5
Debt to Equity ⓘ	0.5	1.2	0.9	0.9	0.8	0.8	0.7	0.6	0.5	0.3	-
Working Cap Days ⓘ	183	338	543	771	3,366	15,099	15,851	1,05,065	7,402	3,641	0
Cash Conv. Cycle ⓘ	101	152	201	187	974	3,505	-6,60,636	24,427	1,861	889	0

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Sales	17.52	12.10	9.51	7.55	1.59	0.34	0.36	0.05	0.74	1.15
Operating Expenses ⓘ +	16.78	10.92	12.43	8.56	2.90	0.73	1.59	0.07	3.13	1.58
Manufacturing Costs	0.78	1.45	1.11	0.86	0.26	0	0	0	0	0
Material Costs	14.41	8.16	9.92	6.61	2.06	0.32	0	0.05	0.35	1.53
Employee Cost	0.74	0.87	0.99	0.76	0.36	0.04	0	0	0.01	0.01
Other Costs ⓘ	0.85	0.44	0.42	0.32	0.23	0.37	1.58	0.02	2.77	0.03
Operating Profit ⓘ	0.74	1.18	-2.92	-1.01	-1.31	-0.39	-1.23	-0.01	-2.39	-0.43
Operating Profit Margin (%)	4.2%	9.7%	-30.7%	-13.4%	-82.2%	-115.0%	-345.0%	-24.2%	-322.0%	-37.7%
Other Income ⓘ +	0.09	0.02	0.11	0.94	1.33	0.38	0.86	0	1.88	0
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	-0.05	-3.34
Interest ⓘ	0.47	0.90	1.24	0.40	0.03	0.03	0	0	1.62	0
Depreciation ⓘ	0.17	0.32	0.41	0.26	0.25	0	0	0	0	0
Profit Before Tax ⓘ	0.20	-0.02	-4.46	-0.73	-0.26	-0.04	-0.37	-0.01	-2.18	-3.77
Tax ⓘ	0.08	0.08	-0.36	0	0	0	0	0	0	0
Profit After Tax	0.12	-0.11	-4.10	-0.73	-0.26	-0.04	-0.37	-0.01	-2.18	-3.77
PAT Margin (%)	0.7%	-0.9%	-43.1%	-9.7%	-16.6%	-12.2%	-103.0%	-24.6%	-294.0%	-329.0%
Adjusted EPS (₹)	0.1	-0.0	-0.7	-0.1	-0.1	-0.0	-0.1	0.0	-0.4	-0.7
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Zyden Gentec - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Equity and Liabilities
Shareholders Fund +	8.58	8.47	12.97	12.63	12.36	12.32	11.95	11.94	9.76	5.98
Share Capital ⓘ	5.07	5.07	11.11	11.11	11.11	11.11	11.11	11.11	11.11	11.11
Reserves ⓘ	3.52	3.41	1.85	1.52	1.25	1.21	0.84	0.83	-1.36	-5.13
Debt +	3.93	9.57	10.70	7.07	5.41	5.17	4.11	4.51	4.54	2.01
Long Term Debt	3.93	2.95	4.33	0	0	0	0	0	0	0
Short Term Debt	0	6.61	6.38	7.07	5.41	5.17	4.11	4.51	4.54	2.01
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	2.77	1.75	1.07	1	1.55	1.21	0.97	0.97	0.08	0.06
Others Liabilities ⓘ	0.44	2.63	1.65	5.60	5.15	4.98	3.94	3.34	0.47	0.07
Total Liabilities ⓘ	15.73	22.42	26.39	26.30	24.47	23.69	20.98	20.75	14.85	8.12
Fixed Assets
Net Fixed Assets ⓘ +	3.70	8.97	8.75	8.53	8.25	8.25	5.33	5.33	0.05	0.05
Gross Block	4.25	9.83	10.02	10.05	9.99	9.99	7.07	7.06	0.07	0.07
Accumulated Depreciation	0.54	0.86	1.27	1.52	1.74	1.74	1.74	1.74	0.02	0.02
CWIP ⓘ	0.62	0.08	0.08	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0.01	0.01	0	0	0	0	0
Inventories	2.92	5.99	2.53	1.27	0.69	0.69	0.69	0.69	0.69	0
Trade Receivables	3.94	3.09	2.15	4.69	4.69	4.11	3.84	4.04	4.31	0.73
Cash Equivalents	0.20	0.25	0.11	0.12	0.03	0.15	0.03	0.10	0.03	0
Others Assets ⓘ	4.34	4.05	12.79	11.68	10.80	10.48	11.09	10.60	9.77	7.35
Total Assets ⓘ	15.73	22.42	26.39	26.30	24.47	23.69	20.98	20.75	14.85	8.12

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Cash Flow From Operating Activity ⓘ +	3.98	-1.61	-1.78	3.69	0.26	-0	-2.36	-0.50	-5.33	0.09
PBT ⓘ	0.20	-0.02	-4.46	-0.73	-0.26	-0.04	-0.37	-0.01	-2.18	-3.77
Adjustment ⓘ	1.07	1.12	1.54	-0.27	-1.03	-0.35	0.69	0	0.87	-0
Changes in Working Capital ⓘ	2.74	-2.67	1.15	4.69	1.55	0.39	-2.12	-0.49	-4.01	3.86
Tax Paid ⓘ	-0.02	-0.03	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ +	-4.68	-4.25	-6.44	0.35	1.34	0.39	2.24	0.50	5.45	2.41
Capex	-0.80	-5.03	-0.20	-0.04	0.02	0	1.91	0	0	-0
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	-3.88	0.79	-6.24	0.39	1.33	0.39	0.33	0.50	5.45	2.42
Cash Flow From Financing Activity ⓘ +	0.85	5.91	8.08	-4.03	-1.69	-0.27	-0	0.07	-0.19	-2.53
Net Proceeds from Shares ⓘ	0.34	0.60	8.10	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	2.78	1.37	-4.33	0	0	0	0.07	0	0
Interest Paid ⓘ	-0.42	-0.82	-1.16	-0.39	-0.03	0	0	0	-0	-0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.94	3.35	-0.24	0.69	-1.65	-0.27	-0	-0	-0.18	-2.53
Net Cash Flow ⓘ	0.16	0.05	-0.14	0.01	-0.09	0.11	-0.12	0.07	-0.07	-0.03

Financial Ratio

PARTICULARS	Mar'10	Mar'11	Mar'12	Mar'13	Mar'14	Mar'15	Mar'16	Mar'17	Mar'18	Mar'19
Ratios
ROE (%)	1.54	-1.27	-38.24	-5.71	-2.12	-0.34	-3.04	-0.11	-20.13	-47.91
ROCE (%)	5.69	5.54	-14.83	-1.36	-0.99	-0.04	-1.75	-0.07	-3.36	-33.84
Asset Turnover Ratio	1.37	0.69	0.42	0.32	0.07	0.02	0.02	0	0.04	0.1
PAT to CFO Conversion(x)	33.17	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	74.70	97.80	92.90	150.30	933.70	4,222.70	4,076.70	0	2,053.80	803.10
Inventory Days	62.90	123.90	151	83.30	195	664.40	710	4,700.40	340.50	0
Payable Days	41.20	101.20	51.90	57.20	225.60	1,593.50	0	7,010.30	542.70	17.30

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

58.42

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zyden Gentec Ltd FAQs

The current trading price of Zyden Gentec on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Zyden Gentec stood at ₹4.83 Cr

The latest P/E ratio of Zyden Gentec as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Zyden Gentec as of 31-Dec-1969 is 0.37.

The 52-week high of Zyden Gentec is ₹0.95 and the 52-week low is ₹0.87.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Zyden Gentec is ₹1.15 ( Cr.) .

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Zyden Gentec Ltd is a below average quality company.

No data found

About Zyden Gentec Ltd

Zyden Gentec was incorporated on April 26, 1994 under the companies Act 1956 as Overseas Capital Private Limited. The name of the company was changed to Overseas Capital Limited on conversion into public limited company on November 11, 1994 and to Zyden Gentec Limited on July 16, 2004. The company was promoted by RK Dhar.

Initially the company was engaged in providing financial services and is presently engaged in the manufacturing of pharmaceuticals and fine chemicals.

Product range of the company includes:

The company's principal activity is to manufacture pharmaceutical products and to provide concultancy services. The company operates in two segments namely Manufacturing & Allied Activities and Financial, Investment & Allied Activities. The products of the company include specialized chemicals, bulk drugs, compounds and intermediates

Drotaverine HCL
Levocetrizine
Ketoconazole
Sildenafil Citrate
Glucosamine
Ciprofloxacin HCL
Enro Floxacin
Bypyridine
Guaifenesin

Zyden Gentec Ltd (530091)

Zyden Gentec Ltd (530091)

Zyden Gentec stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Zyden Gentec - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zyden Gentec Ltd FAQs

About Zyden Gentec Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Zyden Gentec Ltd (530091)

Zyden Gentec Ltd (530091)

Zyden Gentec stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Zyden Gentec - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Zyden Gentec Ltd FAQs

What is the share price of Zyden Gentec?

What is the market cap of Zyden Gentec?

What is the P/E ratio of Zyden Gentec?

What is the P/B ratio of Zyden Gentec?

What is the 52-week high and low of Zyden Gentec?

What is the TTM revenue of Zyden Gentec?

Is Zyden Gentec Ltd a good quality company?

Is Zyden Gentec Ltd undervalued or overvalued?

Is Zyden Gentec Ltd a good buy now?

About Zyden Gentec Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.